The UK Adult ADHD Network (UKAAN) will host its 7th Congress from Thursday 21st to Saturday 23rd September 2017 at the Mermaid Conference and Events Centre in London.
The title of this conference, ADHD in the Mainstream, reflects the increase in recognition and treatment of ADHD by adult mental health services. But despite the fact that ADHD is a common disorder, and despite the fact that the role that ADHD plays in the health of many adults presenting with mental health problems is more recognised, recent evidence suggests that the disorder is still being unrecognised or untreated for many adults using mental health services. Since there is considerable psychiatric morbidity associated with ADHD, this lack of full recognition leads to unnecessary distress to individuals, ineffective targeting of treatments, poor control over chronic mental health problems and the development of adult onset disorders later in life.
Licensed drug treatments for adult ADHD are now available for the first time, including both stimulant and non-stimulant mediation and recommendations from guideline groups such as the National Institute of Health and Clinical Excellence (NICE). The importance of concurrent psychological treatments is also recognised.
Mainstream psychological treatment services need to develop the understanding and skills required to manage mental health problems related to ADHD. This conference, therefore, is designed to raise the level of awareness, knowledge and expertise among health care professionals about people with ADHD and to provide a better understanding of the persistence of the disorder, the development of comorbid mental health problems as well as the delivery of effective treatments.
This conference is relevant for all health care professionals interested in the mental health of people from the adolescent years through to early, middle and later adult life.
The program will be delivered by prominent opinion leaders, clinical experts and internationally recognised investigators and is designed to cover key topics relevant to the diagnosis and treatment of ADHD from adolescence to early and late adulthood. The selection of speakers is particular important so that the audience can hear directly from the most experienced professionals working in this rapidly developing area of clinical psychiatry.
The Scientific Programme, list of speaker, and registration information are all available on UKAAN’s website here https://www.ukaan.org/adhd-in-the-mainstream/
UK Adult ADHD Network (UKAAN) is currently investigating the role of excessive/uncontrolled mind wandering in ADHD. As part of this research they are conducting a survey on mind wandering, ADHD and the links to educational and occupational outcomes, including both potential impairments and benefits (such as creativity) that might be linked to mind wandering in ADHD.
They have already collected a large sample of around 1,000 non-ADHD controls. Now they wish to compare this to findings from patients who have been diagnosed with ADHD. They are therefore looking for clinicians working in adult ADHD clinics to help them by handing out information sheets to patients with ADHD which invites them to take part in this research by completing the online survey.
If you are willing to assist in this research please contact Professor Philip Asherson by email (firstname.lastname@example.org). They would like your name, work address and name of your NHS Trust, or if in a private clinics, just the address of the clinic, to add your site to the current ethics for this work.
If you wish for further information please contact Professor Philip Asherson. He can then send you a copy of their recent publication on this topic, and a rating scale that can be used to measured excessive mind wandering in adults with ADHD.